Zinc finger protein 131 inhibits estrogen signaling by suppressing estrogen receptor alpha homo-dimerization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Yohan | - |
dc.contributor.author | Chung, Kwang Chul | - |
dc.date.accessioned | 2022-07-16T11:28:49Z | - |
dc.date.available | 2022-07-16T11:28:49Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2013-01 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/163591 | - |
dc.description.abstract | Steroid hormone estrogen elicits various physiological functions, many of which are mediated through two structurally and functionally distinct estrogen receptors, ER alpha and ER beta. The functional role of zinc finger protein 131 (ZNF131) is poorly understood, but it is assumed to possess transcriptional regulation activity due to the presence of a DNA binding motif. A few recent reports, including ours, revealed that ZNF131 acts as a negative regulator of ER alpha and that SUMO modification potentiates the negative effect of ZNF131 on estrogen signaling. However, its molecular mechanism for ER alpha, inhibition has not been elucidated in detail. Here, we demonstrate that ZNF131 directly interacts with ER alpha, which consequently inhibits ER alpha-mediated trans-activation by suppressing its homo-dimerization. Moreover, we show that the C-terminal region of ZNF131 containing the SUMOylation site is necessary for its inhibition of estrogen signaling. Taken together, these data suggest that ZNF131 inhibits estrogen signaling by acting as an ER alpha-co-repressor. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.title | Zinc finger protein 131 inhibits estrogen signaling by suppressing estrogen receptor alpha homo-dimerization | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Yohan | - |
dc.identifier.doi | 10.1016/j.bbrc.2012.11.031 | - |
dc.identifier.scopusid | 2-s2.0-84872411500 | - |
dc.identifier.wosid | 000314320700070 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.430, no.1, pp.400 - 405 | - |
dc.relation.isPartOf | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.title | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.volume | 430 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 400 | - |
dc.citation.endPage | 405 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.subject.keywordPlus | HUMAN-BREAST-CANCER | - |
dc.subject.keywordPlus | POZ DOMAIN | - |
dc.subject.keywordPlus | ER-ALPHA | - |
dc.subject.keywordPlus | N-COR | - |
dc.subject.keywordPlus | LIGAND | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | REVEALS | - |
dc.subject.keywordPlus | ZNF131 | - |
dc.subject.keywordPlus | BETA | - |
dc.subject.keywordAuthor | ZNF131 | - |
dc.subject.keywordAuthor | Estrogen signaling | - |
dc.subject.keywordAuthor | ER alpha | - |
dc.subject.keywordAuthor | Repressor | - |
dc.subject.keywordAuthor | Receptor dimerization | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0006291X12021924?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.